Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03459339 · ClinicalTrials.gov registry record · NA
Coordinating Center: Natural History of Barrett's Esophagus Using Tethered Capsule Endomicroscopy
A NA study of Barrett Esophagus, sponsored by Massachusetts General Hospital.
- Active
- Registry status
- NA
- Development phase
- 500
- Enrollment target
- 5
- Study locations
NCT03459339: Active NA study of Barrett Esophagus, sponsored by Massachusetts General Hospital.
NCT03459339 is a NA study of Barrett Esophagus that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 500 participants, below the 3,550-participant average among 32 other Barrett Esophagus trials with a reported enrollment target (86% lower). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03459339, a NA study of Barrett Esophagus, is active but no longer recruiting, sponsored by Massachusetts General Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 500 participants
- Enrollment target
- 5
- Study locations
Study Summary
The goal of this research is to follow Barrett's Esophagus participants for 3 years using the tethered capsule endomicroscopy device with distal scanning and a compact imaging system in a multi-site clinical study.
Conditions Studied
Interventions
- DEVICE Tethered Capsule Endomicroscopy (TCE)
Study Locations (5)
Florida
- Mayo Clinic - Jacksonville - Jacksonville
Massachusetts
- Massachusetts General Hospital - Boston
Minnesota
- Mayo Clinic - Rochester - Rochester
Missouri
- VA Medical Center - Kansas City
New York
- Columbia University Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2017-04-04 |
| Est. Completion | 2028-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03459339
The ClinicalTrials.gov registry entry for NCT03459339 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,550-participant average among 32 other Barrett Esophagus trials with a reported enrollment target (86% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Barrett Esophagus appearing as the primary indexed condition, and to 1 intervention - of which Tethered Capsule Endomicroscopy (TCE) is the first listed.
NCT03459339 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Florida, Massachusetts, Minnesota.
Frequently Asked Questions
What is clinical trial NCT03459339 about?
NCT03459339 is a clinical study titled "Coordinating Center: Natural History of Barrett's Esophagus Using Tethered Capsule Endomicroscopy". The goal of this research is to follow Barrett's Esophagus participants for 3 years using the tethered capsule endomicroscopy device with distal scanning and a compact imaging system in a multi-site clinical study.
What is the current status of trial NCT03459339?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2017-04-04. Estimated completion is 2028-12.
What conditions does trial NCT03459339 study?
This clinical trial studies the following conditions: Barrett Esophagus.
What interventions are being tested in trial NCT03459339?
The interventions under investigation include: Tethered Capsule Endomicroscopy (TCE) (DEVICE).
Who is sponsoring clinical trial NCT03459339?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03459339 being conducted?
This trial has 5 study locations across Florida, Massachusetts, Minnesota, Missouri, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Barrett Esophagus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma
RECRUITING · NA
-
Nonendoscopic Screening for Barrett's Esophagus in Veterans Without Chronic Reflux
RECRUITING · NA
-
Assessment of a Minimally Invasive Collection Device for Molecular Analysis of Esophageal Samples
RECRUITING · NA
-
Wide-Area Transepithelial Sampling in Endoscopic Eradication Therapy for Barrett's Esophagus
RECRUITING · NA
-
Pilot Study for OCT Guided In Vivo Laser Capture Microdissection for Assessing the Prognosis of Barrett's Esophagus
RECRUITING · NA
-
Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance
RECRUITING · NA
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.